MS Patient, Ph.D.: Is 23andMe Doing It Right?
I was conflicted about whether direct-to-consumer DNA analysis services were a good idea, a stance I seemingly share with the FDA
I was conflicted about whether direct-to-consumer DNA analysis services were a good idea, a stance I seemingly share with the FDA
As an MS patient, the last few years have been very exciting on the genetic frontier of...
Clinical Research